Surmodics reported $13.24M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US USD 2.83B 98M
Align Technology ALGN:US USD 410.07M 11.52M
Anika Therapeutics ANIK:US USD 23.05M 1.77M
Arrowhead Research ARWR:US USD 22.65M 8.97M
Baxter International BAX:US USD 986M 204M
Bioscrip BIOS:US USD 148.35M 6.34M
Boston Scientific BSX:US USD 1.16B 31M
Cryolife CRY:US USD 38.6M 2.22M
Edap Tms EDAP:US EUR 5.46M 668K
Edwards Lifesciences EW:US USD 411M 33.7M
Haemonetics HAE:US USD 94.28M 2.14M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Johnson & Johnson JNJ:US USD 6.51B 423M
Merit Medical Systems MMSI:US USD 83.24M 6.54M
Mesa Laboratories MLAB:US USD 19.11M 2.87M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Stryker SYK:US USD 1.59B 109M
Surmodics SRDX:US USD 13.24M 540K